Q32 Bio Inc.
QTTB
$6.30
-$0.52-7.63%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -6.75% | 1,169.64% | |||
| Gross Profit | 1,518.34% | -1,169.64% | |||
| SG&A Expenses | 12.95% | 0.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.71% | -17.38% | |||
| Operating Income | 705.50% | 17.38% | |||
| Income Before Tax | 881.30% | 22.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 881.30% | 22.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 881.30% | 22.13% | |||
| EBIT | 705.50% | 17.38% | |||
| EBITDA | 714.07% | 17.56% | |||
| EPS Basic | 861.30% | 22.41% | |||
| Normalized Basic EPS | 707.42% | 22.40% | |||
| EPS Diluted | 860.27% | 22.62% | |||
| Normalized Diluted EPS | 705.99% | 22.40% | |||
| Average Basic Shares Outstanding | 2.64% | 0.35% | |||
| Average Diluted Shares Outstanding | 2.88% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||